Global Gastrointestinal Disorder Therapeutics Market Growth (Status and Outlook) 2023-2028

Report ID: 1359277 | Published Date: Oct 2024 | No. of Page: 104 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Gastrointestinal Disorder Therapeutics Market Size 2017-2028
        2.1.2 Gastrointestinal Disorder Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Gastrointestinal Disorder Therapeutics Segment by Type
        2.2.1 Irritable Bowel Syndrome (IBS)
        2.2.2 Chronic Constipation (CC)
        2.2.3 Ulcerative Colitis (UC)
    2.3 Gastrointestinal Disorder Therapeutics Market Size by Type
        2.3.1 Gastrointestinal Disorder Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)
    2.4 Gastrointestinal Disorder Therapeutics Segment by Application
        2.4.1 Hospitals
        2.4.2 Clinics
        2.4.3 Others
    2.5 Gastrointestinal Disorder Therapeutics Market Size by Application
        2.5.1 Gastrointestinal Disorder Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)
3 Gastrointestinal Disorder Therapeutics Market Size by Player
    3.1 Gastrointestinal Disorder Therapeutics Market Size Market Share by Players
        3.1.1 Global Gastrointestinal Disorder Therapeutics Revenue by Players (2020-2022)
        3.1.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Players (2020-2022)
    3.2 Global Gastrointestinal Disorder Therapeutics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Gastrointestinal Disorder Therapeutics by Regions
    4.1 Gastrointestinal Disorder Therapeutics Market Size by Regions (2017-2022)
    4.2 Americas Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)
    4.3 APAC Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)
    4.4 Europe Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)
    4.5 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022)
    5.2 Americas Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)
    5.3 Americas Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022)
    6.2 APAC Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)
    6.3 APAC Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Gastrointestinal Disorder Therapeutics by Country (2017-2022)
    7.2 Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)
    7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Gastrointestinal Disorder Therapeutics by Region (2017-2022)
    8.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022)
    8.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Gastrointestinal Disorder Therapeutics Market Forecast
    10.1 Global Gastrointestinal Disorder Therapeutics Forecast by Regions (2023-2028)
        10.1.1 Global Gastrointestinal Disorder Therapeutics Forecast by Regions (2023-2028)
        10.1.2 Americas Gastrointestinal Disorder Therapeutics Forecast
        10.1.3 APAC Gastrointestinal Disorder Therapeutics Forecast
        10.1.4 Europe Gastrointestinal Disorder Therapeutics Forecast
        10.1.5 Middle East & Africa Gastrointestinal Disorder Therapeutics Forecast
    10.2 Americas Gastrointestinal Disorder Therapeutics Forecast by Country (2023-2028)
        10.2.1 United States Gastrointestinal Disorder Therapeutics Market Forecast
        10.2.2 Canada Gastrointestinal Disorder Therapeutics Market Forecast
        10.2.3 Mexico Gastrointestinal Disorder Therapeutics Market Forecast
        10.2.4 Brazil Gastrointestinal Disorder Therapeutics Market Forecast
    10.3 APAC Gastrointestinal Disorder Therapeutics Forecast by Region (2023-2028)
        10.3.1 China Gastrointestinal Disorder Therapeutics Market Forecast
        10.3.2 Japan Gastrointestinal Disorder Therapeutics Market Forecast
        10.3.3 Korea Gastrointestinal Disorder Therapeutics Market Forecast
        10.3.4 Southeast Asia Gastrointestinal Disorder Therapeutics Market Forecast
        10.3.5 India Gastrointestinal Disorder Therapeutics Market Forecast
        10.3.6 Australia Gastrointestinal Disorder Therapeutics Market Forecast
    10.4 Europe Gastrointestinal Disorder Therapeutics Forecast by Country (2023-2028)
        10.4.1 Germany Gastrointestinal Disorder Therapeutics Market Forecast
        10.4.2 France Gastrointestinal Disorder Therapeutics Market Forecast
        10.4.3 UK Gastrointestinal Disorder Therapeutics Market Forecast
        10.4.4 Italy Gastrointestinal Disorder Therapeutics Market Forecast
        10.4.5 Russia Gastrointestinal Disorder Therapeutics Market Forecast
    10.5 Middle East & Africa Gastrointestinal Disorder Therapeutics Forecast by Region (2023-2028)
        10.5.1 Egypt Gastrointestinal Disorder Therapeutics Market Forecast
        10.5.2 South Africa Gastrointestinal Disorder Therapeutics Market Forecast
        10.5.3 Israel Gastrointestinal Disorder Therapeutics Market Forecast
        10.5.4 Turkey Gastrointestinal Disorder Therapeutics Market Forecast
        10.5.5 GCC Countries Gastrointestinal Disorder Therapeutics Market Forecast
    10.6 Global Gastrointestinal Disorder Therapeutics Forecast by Type (2023-2028)
    10.7 Global Gastrointestinal Disorder Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Information
        11.1.2 AstraZeneca Gastrointestinal Disorder Therapeutics Product Offered
        11.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 AstraZeneca Main Business Overview
        11.1.5 AstraZeneca Latest Developments
    11.2 Takeda Pharmaceutical
        11.2.1 Takeda Pharmaceutical Company Information
        11.2.2 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Offered
        11.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Takeda Pharmaceutical Main Business Overview
        11.2.5 Takeda Pharmaceutical Latest Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Information
        11.3.2 Johnson & Johnson Gastrointestinal Disorder Therapeutics Product Offered
        11.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Johnson & Johnson Main Business Overview
        11.3.5 Johnson & Johnson Latest Developments
    11.4 Eisai
        11.4.1 Eisai Company Information
        11.4.2 Eisai Gastrointestinal Disorder Therapeutics Product Offered
        11.4.3 Eisai Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Eisai Main Business Overview
        11.4.5 Eisai Latest Developments
    11.5 Abbott Laboratories
        11.5.1 Abbott Laboratories Company Information
        11.5.2 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Offered
        11.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Abbott Laboratories Main Business Overview
        11.5.5 Abbott Laboratories Latest Developments
    11.6 Salix Pharmaceuticals
        11.6.1 Salix Pharmaceuticals Company Information
        11.6.2 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Offered
        11.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Salix Pharmaceuticals Main Business Overview
        11.6.5 Salix Pharmaceuticals Latest Developments
    11.7 Bausch Health
        11.7.1 Bausch Health Company Information
        11.7.2 Bausch Health Gastrointestinal Disorder Therapeutics Product Offered
        11.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Bausch Health Main Business Overview
        11.7.5 Bausch Health Latest Developments
    11.8 Allergan
        11.8.1 Allergan Company Information
        11.8.2 Allergan Gastrointestinal Disorder Therapeutics Product Offered
        11.8.3 Allergan Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Allergan Main Business Overview
        11.8.5 Allergan Latest Developments
    11.9 Bayer
        11.9.1 Bayer Company Information
        11.9.2 Bayer Gastrointestinal Disorder Therapeutics Product Offered
        11.9.3 Bayer Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Bayer Main Business Overview
        11.9.5 Bayer Latest Developments
    11.10 UCB
        11.10.1 UCB Company Information
        11.10.2 UCB Gastrointestinal Disorder Therapeutics Product Offered
        11.10.3 UCB Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 UCB Main Business Overview
        11.10.5 UCB Latest Developments
    11.11 AbbVie
        11.11.1 AbbVie Company Information
        11.11.2 AbbVie Gastrointestinal Disorder Therapeutics Product Offered
        11.11.3 AbbVie Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 AbbVie Main Business Overview
        11.11.5 AbbVie Latest Developments
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Information
        11.12.2 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Offered
        11.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 GlaxoSmithKline Main Business Overview
        11.12.5 GlaxoSmithKline Latest Developments
    11.13 Astellas Pharma
        11.13.1 Astellas Pharma Company Information
        11.13.2 Astellas Pharma Gastrointestinal Disorder Therapeutics Product Offered
        11.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Astellas Pharma Main Business Overview
        11.13.5 Astellas Pharma Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Gastrointestinal Disorder Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Irritable Bowel Syndrome (IBS)
    Table 3. Major Players of Chronic Constipation (CC)
    Table 4. Major Players of Ulcerative Colitis (UC)
    Table 5. Gastrointestinal Disorder Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 6. Global Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 7. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)
    Table 8. Gastrointestinal Disorder Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 9. Global Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 10. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)
    Table 11. Global Gastrointestinal Disorder Therapeutics Revenue by Players (2020-2022) & ($ Millions)
    Table 12. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Player (2020-2022)
    Table 13. Gastrointestinal Disorder Therapeutics Key Players Head office and Products Offered
    Table 14. Gastrointestinal Disorder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 15. New Products and Potential Entrants
    Table 16. Mergers & Acquisitions, Expansion
    Table 17. Global Gastrointestinal Disorder Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
    Table 18. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Regions (2017-2022)
    Table 19. Americas Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & ($ Millions)
    Table 20. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Country (2017-2022)
    Table 21. Americas Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 22. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)
    Table 23. Americas Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 24. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)
    Table 25. APAC Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022) & ($ Millions)
    Table 26. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Region (2017-2022)
    Table 27. APAC Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 28. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)
    Table 29. APAC Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 30. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)
    Table 31. Europe Gastrointestinal Disorder Therapeutics Market Size by Country (2017-2022) & ($ Millions)
    Table 32. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Country (2017-2022)
    Table 33. Europe Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 34. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)
    Table 35. Europe Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 36. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)
    Table 37. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Region (2017-2022) & ($ Millions)
    Table 38. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Region (2017-2022)
    Table 39. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Type (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Type (2017-2022)
    Table 41. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Application (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Application (2017-2022)
    Table 43. Key Market Drivers & Growth Opportunities of Gastrointestinal Disorder Therapeutics
    Table 44. Key Market Challenges & Risks of Gastrointestinal Disorder Therapeutics
    Table 45. Key Industry Trends of Gastrointestinal Disorder Therapeutics
    Table 46. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 47. Global Gastrointestinal Disorder Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
    Table 48. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 49. Global Gastrointestinal Disorder Therapeutics Market Size Market Share Forecast by Type (2023-2028)
    Table 50. Global Gastrointestinal Disorder Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 51. Global Gastrointestinal Disorder Therapeutics Market Size Market Share Forecast by Application (2023-2028)
    Table 52. AstraZeneca Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 53. AstraZeneca Gastrointestinal Disorder Therapeutics Product Offered
    Table 54. AstraZeneca Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 55. AstraZeneca Main Business
    Table 56. AstraZeneca Latest Developments
    Table 57. Takeda Pharmaceutical Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 58. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product Offered
    Table 59. Takeda Pharmaceutical Main Business
    Table 60. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 61. Takeda Pharmaceutical Latest Developments
    Table 62. Johnson & Johnson Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 63. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product Offered
    Table 64. Johnson & Johnson Main Business
    Table 65. Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 66. Johnson & Johnson Latest Developments
    Table 67. Eisai Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 68. Eisai Gastrointestinal Disorder Therapeutics Product Offered
    Table 69. Eisai Main Business
    Table 70. Eisai Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 71. Eisai Latest Developments
    Table 72. Abbott Laboratories Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 73. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product Offered
    Table 74. Abbott Laboratories Main Business
    Table 75. Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 76. Abbott Laboratories Latest Developments
    Table 77. Salix Pharmaceuticals Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 78. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product Offered
    Table 79. Salix Pharmaceuticals Main Business
    Table 80. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 81. Salix Pharmaceuticals Latest Developments
    Table 82. Bausch Health Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 83. Bausch Health Gastrointestinal Disorder Therapeutics Product Offered
    Table 84. Bausch Health Main Business
    Table 85. Bausch Health Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 86. Bausch Health Latest Developments
    Table 87. Allergan Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 88. Allergan Gastrointestinal Disorder Therapeutics Product Offered
    Table 89. Allergan Main Business
    Table 90. Allergan Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 91. Allergan Latest Developments
    Table 92. Bayer Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 93. Bayer Gastrointestinal Disorder Therapeutics Product Offered
    Table 94. Bayer Main Business
    Table 95. Bayer Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 96. Bayer Latest Developments
    Table 97. UCB Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 98. UCB Gastrointestinal Disorder Therapeutics Product Offered
    Table 99. UCB Main Business
    Table 100. UCB Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 101. UCB Latest Developments
    Table 102. AbbVie Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 103. AbbVie Gastrointestinal Disorder Therapeutics Product Offered
    Table 104. AbbVie Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 105. AbbVie Main Business
    Table 106. AbbVie Latest Developments
    Table 107. GlaxoSmithKline Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 108. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product Offered
    Table 109. GlaxoSmithKline Main Business
    Table 110. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 111. GlaxoSmithKline Latest Developments
    Table 112. Astellas Pharma Details, Company Type, Gastrointestinal Disorder Therapeutics Area Served and Its Competitors
    Table 113. Astellas Pharma Gastrointestinal Disorder Therapeutics Product Offered
    Table 114. Astellas Pharma Main Business
    Table 115. Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 116. Astellas Pharma Latest Developments
List of Figures
    Figure 1. Gastrointestinal Disorder Therapeutics Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Gastrointestinal Disorder Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Type in 2021
    Figure 7. Gastrointestinal Disorder Therapeutics in Hospitals
    Figure 8. Global Gastrointestinal Disorder Therapeutics Market: Hospitals (2017-2022) & ($ Millions)
    Figure 9. Gastrointestinal Disorder Therapeutics in Clinics
    Figure 10. Global Gastrointestinal Disorder Therapeutics Market: Clinics (2017-2022) & ($ Millions)
    Figure 11. Gastrointestinal Disorder Therapeutics in Others
    Figure 12. Global Gastrointestinal Disorder Therapeutics Market: Others (2017-2022) & ($ Millions)
    Figure 13. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021
    Figure 14. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Player in 2021
    Figure 15. Global Gastrointestinal Disorder Therapeutics Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Gastrointestinal Disorder Therapeutics Value Market Share by Country in 2021
    Figure 21. Americas Gastrointestinal Disorder Therapeutics Consumption Market Share by Type in 2021
    Figure 22. Americas Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021
    Figure 23. United States Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Region in 2021
    Figure 28. APAC Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021
    Figure 29. China Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Country in 2021
    Figure 36. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Type in 2021
    Figure 37. Europe Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021
    Figure 38. Germany Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size Market Share by Application in 2021
    Figure 46. Egypt Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Gastrointestinal Disorder Therapeutics Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 55. United States Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 59. China Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 63. India Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 66. France Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 67. UK Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Gastrointestinal Disorder Therapeutics Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Gastrointestinal Disorder Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Gastrointestinal Disorder Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Gastrointestinal Disorder Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports